Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01996852 · ClinicalTrials.gov registry record · NA
Improving Erectile Function and Quality of Life After Prostate Cancer Treatment
A NA study, sponsored by Case Comprehensive Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT01996852 is a NA study that was terminated before completion, run by Case Comprehensive Cancer Center. The registered enrollment target is 34 participants.
The verdict
NCT01996852, a NA study, was terminated before completion, sponsored by Case Comprehensive Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
This is a research study of erectile dysfunction (ED) in men diagnosed with prostate cancer. 144 patients and partners will participate in the study. The purpose of this study is to test a new treatment that combines a cognitive-behavioral intervention with medication and a vacuum constrictive device to treat ED. This new treatment consists of multiple therapeutic elements that enhance compliance with medical treatment and increase sexual activity through enhancement of the sensual pleasure of sex and partner support.
Interventions
- DRUG sildenafil citrate
- BEHAVIORAL Cognitive-behavioral Meetings
- DEVICE Vacuum Constriction Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2013-07 |
| Est. Completion | 2016-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01996852
The ClinicalTrials.gov registry entry for NCT01996852 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which sildenafil citrate is the first listed.
NCT01996852 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01996852 about?
NCT01996852 is a clinical study titled "Improving Erectile Function and Quality of Life After Prostate Cancer Treatment". This is a research study of erectile dysfunction (ED) in men diagnosed with prostate cancer. 144 patients and partners will participate in the study. The purpose of this study is to test a new treatment that combines a cognitive-behavioral intervention with medication and a vacuum constrictive devic...
What is the current status of trial NCT01996852?
This trial is currently terminated. It is a NA study. The enrollment target is 34 participants. The study started on 2013-07. Estimated completion is 2016-08.
What interventions are being tested in trial NCT01996852?
The interventions under investigation include: sildenafil citrate (DRUG), Cognitive-behavioral Meetings (BEHAVIORAL), Vacuum Constriction Device (DEVICE).
Who is sponsoring clinical trial NCT01996852?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.